![]() |
|
|
1 Laboratory of Preclinical Pharmacology, National Institute of Mental Health, Saint Elizabeths Hospital, William A. White Building, Washington, D.C.
One of the major metabolites of norepinephrine in rat brain is 3-methoxy-4-hydroxyphenylethyleneglycol sulfate (MOPEG-SO4). The rate of formation in brain of MOPEG-SO4 was estimated by: 1) determining the rate of its accumulation after treatment with probenecid and 2) determining the initial rate of decline of MOPEG-SO4, after inhibition of monoamine oxidase with pargyline. The rate of formation of MOPEG-SO4, appeared to be about 20 to 35% of the rate previously reported for norepinephrine. We also observed that increasing the turnover of norepinephrine by injection of phenoxybenzamine increased the rate of formation and the concentration of MOPEG-SO4 in brain. Cold exposure, which also accelerates the rate of formation of norepinephrine in brain, increased the concentration of MOPEG-SO4 in brain. Neither treatment had an appreciable effect on the steady-state concentration of norepinephrine. Measuring MOPEG-SO4 formation by the above procedures or simply measuring the concentration of MOPEG-SO4 may be a useful technique for revealing changes in the synthesis of norepinephrine in rat brain.
Submitted on June 7, 1972
This article has been cited by other articles:
![]() |
T. Keeton, H Krutzsch, and W Lovenberg Specific and sensitive radioimmunoassay for 3-methoxy-4-hydroxyphenylethyleneglycol (MOPEG) Science, February 6, 1981; 211(4482): 586 - 588. [Abstract] [PDF] |
||||
![]() |
G Cassens, M Roffman, A Kuruc, P. Orsulak, and J. Schildkraut Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock Science, September 5, 1980; 209(4461): 1138 - 1140. [Abstract] [PDF] |
||||